कंपनी का अवलोकन
Terra Innovatum Global N.V. operates within the Utilities sector, specifically focusing on the Regulated Electric industry, where it develops micro-modular nuclear reactor technologies to provide carbon-free baseload power solutions ranging from megawatts to gigawatts. The company's primary product, known as SOLO, is designed to generate 1 MWe of electricity, addressing global energy needs through advanced nuclear energy technology while maintaining a streamlined organizational structure. In terms of scale, Terra Innovatum Global N.V. holds a market capitalization of $318.46M, yet it reports a TTM annual revenue of N/A and employs only 1 individual according to the available data. This unique valuation profile suggests a significant discrepancy between its market price and its current operational output, indicating that the market may be pricing in future potential rather than existing cash flows, as the company's financials currently reflect minimal active revenue generation despite its specialized technological focus.
वित्तीय स्वास्थ्य
The company reports a Net Income (TTM) of $-5,649,581, while Revenue (TTM) and EBITDA figures are listed as N/A, revealing a cost structure where operational expenses and losses are substantial relative to current income generation capabilities. Free Cash Flow is reported as N/A, which implies that the company is currently consuming cash reserves rather than generating surplus liquidity from its operations to fund expansion or debt repayment. All three margin metrics—Gross Margin, Operating Margin, and Profit Margin—are recorded at 0.0%, indicating that the company has not yet achieved positive profitability or cost recovery on its sales, likely due to the high capital intensity inherent in developing nuclear reactor technology. Regarding liquidity, the company holds $2.15M in Cash against $3.88M in Debt, creating a situation where liabilities exceed liquid assets, and the Debt to Equity ratio is N/A due to the absence of equity earnings data. The Current Ratio stands at 0.49, a figure below 1.0 that signifies the company possesses fewer current assets than current liabilities, pointing to potential short-term liquidity challenges in meeting its immediate obligations. Furthermore, Return on Equity and Return on Assets are both N/A, demonstrating that the management has not yet generated positive returns on the capital invested by shareholders or the total asset base.
मूल्यांकन आकलन
The Trailing P/E Ratio (TTM) is N/A due to the negative net income, while the Forward P/E is -23.35, a negative figure that reflects the market's expectation of continued losses rather than imminent profitability in the near term. The Price to Book ratio is -75.50, an extremely negative value that indicates the market is valuing the company well below its book value, a common characteristic for distressed or pre-revenue biotech or technology firms, yet it also suggests significant uncertainty regarding the asset's liquidation value. Price to Sales and EV/EBITDA metrics are both N/A, meaning traditional sales-based or earnings-based valuation models cannot be applied to assess the company's current worth without further data confirmation. The stock has traded between a 52-Week High of $21.91 and a 52-Week Low of $3.73, showing a wide volatility range that highlights the speculative nature of the investment. Although the Beta is N/A, preventing a direct comparison to market volatility, the wide spread between the high and low prices suggests that the stock price is highly sensitive to market sentiment regarding nuclear energy developments.
Growth & Income
Revenue Growth (YoY) and Earnings Growth (YoY) are both listed as N/A, which precludes any analysis of growth rates but implies that the company is in a development phase where historical growth data is not yet available for comparison. The company does not pay dividends, evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, meaning that all available resources are being retained within the company to fund research, development, and the scaling of its micro-modular nuclear reactor projects rather than being distributed to shareholders. The 0.0% payout ratio is sustainable in the context of a non-dividend payer, as the company is choosing to reinvest earnings—or in this case, capital reserves—into its primary business objectives rather than providing income to investors. Consequently, the overall growth and income profile of Terra Innovatum Global N.V. is characterized by a complete absence of current income generation and a reliance on external capital or internal reserves to fuel its technological advancement without returning value to shareholders in the form of cash distributions.